Browsing by Author Taylor, Kerry

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 5 of 5
Issue DateTitleAuthor(s)Citation
2003Imatinib produces significantly superior molecular responses compared to interferon alfa plus cytarabine in patients with newly disgnosed chronic myeloid leukemia in chronic phaseBradstock, Kenneth; Arthur, C.; Branford, Susan; Browett, Peter; Durrant, Simon; Gathmann, I.; Grigg, Andrew P.; Harper, A.; Hughes, T. P.; Joske, D.; Lynch, Kevin; Ma, D.; Rudzki, Zbigniew; Schwarer, Anthony; Seymour, John F.; Taylor, Kerry; Western Clinical School: Westmead Millennium InstituteImatinib produces significantly superior molecular responses compared to interferon alfa plus cytarabine in patients with newly disgnosed chronic myeloid leukemia in chronic phase, Leukemia, vol.17,(12),2003,pp 2401-2409
2015An imatinib-only window followed by imatinib and chemotherapy for Philadelphia chromosome-positive acute leukemia: long-term results of the CMLALL1 trialBradstock, Kenneth; Arthur, Christopher; Durrant, Simon; et al, Various; Filshie, Robin; Grigg, Andrew P.; Hughes, Timothy P; Irving, Ian; Lickliter, Jason D; Szer, Jeffrey; Taylor, Kerry; Western Clinical School: Westmead Institute for Medical ResAn imatinib-only window followed by imatinib and chemotherapy for Philadelphia chromosome-positive acute leukemia: long-term results of the CMLALL1 trial, Leukemia & Lymphoma, vol.56, 3, 2015,pp 630-638
2005A randomized trial of high- versus conventional-dose cytarabine in consolidation chemotherapy for adult de novo acute myeloid leukemia in first remission after induction therapy containing high-dose cytarabine.Bradstock, Kenneth; Brighton, Timothy; Joshua, Douglas; Koutts, Jerry; Young, Graham; Arthur, C; Bashford, J; Baxter, Heather; Cannell, P; Catalano, J; Dunlop, L; Durrant, S; Eliadis, P; Enno, Arno; Gill, D; Gillett, A; Juneja, S K; Leahy, M; Lowenthal, Raymond M.; Matthews, J P; Schwarer, A; Szer, J.; Taylor, Kerry; Western Clinical School: Westmead Millennium Institute; School of Public Health: NH&MRC Clinical Trials Centre; Central Clinical School: Medicine; Western Clinical School: Pathology; Central Clinical School: MedicineA randomized trial of high- versus conventional-dose cytarabine in consolidation chemotherapy for adult de novo acute myeloid leukemia in first remission after induction therapy containing high-dose cytarabine., Blood 2005, vol.105,(2),2005,pp 481-488
2004Real-Time Quantitative Pcr Analysis Can Be Used As A Primary Screen To Identify Patients With Cml Treated With Imatinib Who Have Bcr-Abl Kinase Domain Mutations.Bradstock, Kenneth; Branford, Susan; Browett, Peter; Durrant, Simon; et, al; Grigg, Andrew P.; Parkinson, Ian; Rudzki, Zbigniew; Schwarer, Anthony; Seymour, John F.; Taylor, Kerry; Western Clinical School: Westmead Millennium InstituteReal-Time Quantitative Pcr Analysis Can Be Used As A Primary Screen To Identify Patients With Cml Treated With Imatinib Who Have Bcr-Abl Kinase Domain Mutations., Blood, vol.104,(9),2004,pp 2926-2932
2012Results of the APML3 trial incorporating all-trans-retinoic acid and idarubicin in both induction and consolidation as initial therapy for patients with acute promyelocytic leukemiaBradstock, Kenneth; Hertzberg, Mark; Iland, Harry; Brighton, Tim; Browett, Peter; Cannell, P; Catalano, J; Deveridge, Sandra; et al, various; Grigg, A; Horvath, Noemi; Seymour, John F.; Taylor, Kerry; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead); Central Clinical School: MedicineResults of the APML3 trial incorporating all-trans-retinoic acid and idarubicin in both induction and consolidation as initial therapy for patients with acute promyelocytic leukemia, Haematologica: the hematology journal, vol.97, 2, 2012,pp 227-234